FDA approves blood test to detect colon cancer for those at average risk
(NEW YORK) -- The U.S. Food and Drug Administration on Monday morning approved a blood test to screen for colorectal cancer in certain individuals.The blood test, known as Shield and manufactured by Guardant Health, is already commercially available, but FDA approval will help broaden...
